The official blog of the Lung Institute.

The White House and Vatican Agree: Cellular Therapy Shows Good Promise to Cure Diseases

5 Jan 2016
| Under Press | Posted by
The White House and Vatican show support for regenerative medicine

The Lung Institute works to advance the field of regenerative medicine, the field garnering support from organizations like the White House and Vatican.

TAMPA, Fla. – January 5, 2015: The Lung Institute is excited to announce that cellular therapy is gaining worldwide support from key influencers including the White House and Vatican. U.S. Congress just passed the Stem Cell Therapeutic and Research Reauthorization Act on Dec. 16, securing cellular therapy industry funding for at least 5 more years. The Vatican also showed their support for cellular therapy earlier this year, announcing The Third International Conference on the Progress of Regenerative Medicine and its Cultural Impact to be held within the Vatican April 28-30, 2016.

“It remains one of the best kept secrets in America that umbilical cord blood cells and adult cells in general are curing people of a myriad of terrible conditions and diseases in adults as well as children,” stated U.S. Rep. Chris Smith.

The Vatican released a similar statement regarding the benefits of regenerative medicine. “The new field of regenerative medicine holds great promise to alleviate the pain and suffering for hundreds of millions of people around the world. We must unite to discover and advance such new therapies, and find ways to bring them to all those in need,” said Cardinal Gianfranco Ravasi, president of the Pontifical Council for Culture.

Regenerative medicine is indeed helping people, providing alternatives to highly invasive or chemical treatments of the past. The Lung Institute specializes in treating people who suffer from debilitating lung diseases like chronic obstructive pulmonary disease (COPD) using cellular therapy. The Lung Institute uses autologous cells, meaning the cells are derived from a patient’s own body. Lung Institute doctor Jack Coleman, Jr., M.D. recently wrote a white paper with data that shows an average increase in pulmonary function among Lung Institute patients as a result of receiving cellular therapy.

Not only are doctors seeing improved test results, patients have noticed improvements in their quality of life too. “I wanted to be able to do all my activities of daily living without being short of breath, which is showering and all that stuff…and I do,” stated Lung Institute patient Becky D. “I wanted to be able to walk across a soccer field to see my grandson play soccer, and I can. I wanted to be able to dance a little again, and I did.”

About the Lung Institute

The Lung Institute, founded in 2013, is a leading medical provider of regenerative cellular therapy for lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and interstitial lung disease in the United States. Based in Tampa, Fla., the Lung Institute currently has clinics in Nashville, Tenn., Scottsdale, Ariz., and Pittsburgh, Pa., with plans to open three new locations in 2016. To date the organization has treated over 1,500 patients, helping them breathe easier in their fight against lung disease. For more information, please visit www.lunginstitute.com or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.